Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROUD HIV PrEP pilot trial
2012-002373-56Phase 4Completed
- Sponsor
- Medical Research Council
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Medical Research Council. Primary endpoint: Feasibility of recruitment and retention. Started Sep 2012; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-002373-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002373-56.